Keywords: R&A oursourcing, Shifting to China and India, Booz & Co

Biotech firms will increase R&D outsourcing and shift it overseas, finds Booz study

Article | 08 March 2012

As biopharmaceutical companies look to cut costs and improve speed-to-market, more of them plan to outsource R&D and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in